-
The FDA has approved a new lipid regulating agentthe ethyl esters of omega-3 fatty acids for the treatment of high triglyceride levels.
-
This meta-analysis reviewed trials of antioxidants for prevention of GI cancer.
-
Inhaled corticosteroids are the most effective pharmacologic agents in reducing exacerbations in asthmatics.
-
The newer, more potent, statin drugs are capable of reducing LDL cholesterol safely and tolerably in most patients thus making a target LDL of 50-70 mg/dL a practical goal, but how low is too low?
-
An NIH Consensus Panel has announced new recommendations for the diagnosis of celiac disease using new serologic testing.
-
Peripheral arterial disease may be stratified in severity by the ankle-brachial index, measured by dividing the ankle systolic BP by the brachial systolic BP.
-
The FDA has approved duloxetine for the treatment of depression and the management of the pain associated with diabetic peripheral neuropathy.
-
In an observational study, enabled by a powerful drug-dispensing record linkage system, statin use among a large number of patients treated with cardiovascular drugs was associated with a 20% reduction in incipient cancer diagnosis over a 7-year period.
-
Patients treated with spironolactone and ACE inhibitors for congestive heart failure have a markedly increased risk of hyperkalemia.
-
At this time, BNP seems to be a useful initial test that should not be repeated during short hospital stays.